| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 20 |
| 1 | ERGOCALCIFEROL | 16 |
| 2 | ABALOPARATIDE | 15 |
| 3 | ACETAMINOPHEN | 15 |
| 4 | GABAPENTIN | 15 |
| 5 | BUDESONIDE | 11 |
| 6 | PREDNISONE | 11 |
| 7 | CARBAMAZEPINE | 10 |
| 8 | FUROSEMIDE | 10 |
| 9 | IBUPROFEN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, AND SODIUM CHLORIDE FOR ORAL SOLUTION | 1 | 0.0093 |
| 1 | ALITRETINOIN | 1 | 0.0084 |
| 2 | OLUTASIDENIB | 2 | 0.0069 |
| 3 | MITAPIVAT | 9 | 0.0068 |
| 4 | ACETAMINOPHEN AND IBUPROFEN | 1 | 0.0045 |
| 5 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0030 |
| 6 | ACETAMINOPHEN, IBUPROFEN | 1 | 0.0027 |
| 7 | AFICAMTEN | 1 | 0.0020 |
| 8 | ZILEUTON | 1 | 0.0015 |
| 9 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 1 | Corticosteroid [EPC] | 24 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 20 |
| 3 | Provitamin D2 Compound [EPC] | 16 |
| 4 | Parathyroid Hormone-Related Peptide Analog [EPC] | 15 |
| 5 | Mood Stabilizer [EPC] | 14 |
| 6 | Loop Diuretic [EPC] | 13 |
| 7 | Atypical Antipsychotic [EPC] | 12 |
| 8 | Kinase Inhibitor [EPC] | 11 |
| 9 | GLP-1 Receptor Agonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyruvate Kinase Activator [EPC] | 9 | 0.0068 |
| 1 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 4 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 5 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 1 | 0.0005 |
| 6 | Parathyroid Hormone-Related Peptide Analog [EPC] | 15 | 0.0005 |
| 7 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 8 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Carnitine Analog [EPC] | 1 | 0.0003 |